United States · FDA National Drug Code directory
Mavyret
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0074-2625_c1aa97e0-7350-4286-ac17-915bcdf0b08a
- Product NDC
- 0074-2625
- Form
- TABLET, FILM COATED
- Composition / generic term
- Glecaprevir and Pibrentasvir
- Labeler
- AbbVie Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170803
- Source listing expiry
- 20271231
Source-listed ingredients
- PIBRENTASVIR — 40 mg/1
- GLECAPREVIR — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 CARTON (0074-2625-04) / 7 BLISTER PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 BLISTER PACK · 0074-2625-04
- 4 CARTON in 1 CARTON (0074-2625-28) / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK · 0074-2625-28
- 2 CARTON in 1 CARTON (0074-2625-56) / 4 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK · 0074-2625-56
- 84 TABLET, FILM COATED in 1 BOTTLE (0074-2625-84) · 0074-2625-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →